\
&
Contact us
Partnership website: https://www.ihi.europa.eu/
The Innovative Health Initiative (IHI) is a partnership between the European Union and industry associations representing the sectors involved in healthcare, namely COCIR (medical imaging, radiotherapy, health ICT and electromedical industries); EFPIA, including Vaccines Europe (pharmaceutical industry and vaccine industry); EuropaBio (biotechnology industry); and MedTech Europe (medical technology industry).
IHI is the successor of the Innovative Medicines Initiative (IMI), the world’s largest public-private collaboration in life sciences.
The partnership intends to
It will cover the entire continuum of care, from prevention and diagnostics to treatment and disease management.
The following organisations based in Flanders are partner in ongoing IHI projects (2022 calls):
Governance of IHI: The IHI States Representatives Group consists of representatives of the EU Member States & countries associated to Horizon Europe. The group is consulted on a range of issues, including the draft call topics. In this group, the Flemish government is represented by Kathleen D'Hondt.
Since it took off in 2021, IHI has launched several calls of proposals. Information on topics that are in the pipeline can be found on IHI's 'future opportunities' webpage. Information on calls that are currently open can be found on IHI's open calls webpage.
Currently, there is a call forthcoming - foreseen to be launched in Q2 2025:
All IHI calls for proposals are also published on the European Commission’s Funding & Tenders Portal. Find out more on how IHI call topics are generated here.
Innovative Health Initiative contact page Contact | IHI Innovative Health Initiative (europa.eu) or infodesk@ihi.europa.eu
Partnerships group the EC and private and/or public partners, to coordinate and streamline the research & innovation initiatives and funding in some selected key domains.
The ROOT project obtained funding under Horizon 2020 topic ‘EGNSS applications fostering societal resilience and protecting the environment’. The project, which ran from November 2020 to July 2022, aimed to demonstrate the benefit of Galileo OSNMA signal to increase the robustness of critical telecom infrastructures.
The Flanders-based company Septentrio contributed substantially to completing this objective together with the other ROOT partners. The results of the project partially close a gap in the security of telecommunication networks dependent on satellite-derived time, with indirect benefits in curbing illegal attempts to disrupt network services.
